These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 11472109

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sustained liver-specific transgene expression from the albumin promoter in mice following hydrodynamic plasmid DNA delivery.
    Wooddell CI, Reppen T, Wolff JA, Herweijer H.
    J Gene Med; 2008 May; 10(5):551-63. PubMed ID: 18330848
    [Abstract] [Full Text] [Related]

  • 3. Sustained, high transgene expression in liver with plasmid vectors using optimized promoter-enhancer combinations.
    Magnusson T, Haase R, Schleef M, Wagner E, Ogris M.
    J Gene Med; 2011 Jul; 13(7-8):382-91. PubMed ID: 21721074
    [Abstract] [Full Text] [Related]

  • 4. Increased duration of transgene expression in the lung with plasmid DNA vectors harboring adenovirus E4 open reading frame 3.
    Yew NS, Marshall J, Przybylska M, Wysokenski DM, Ziegler RJ, Rafter PW, Li C, Armentano D, Cheng SH.
    Hum Gene Ther; 1999 Jul 20; 10(11):1833-43. PubMed ID: 10446923
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression.
    Liu BH, Wang X, Ma YX, Wang S.
    Gene Ther; 2004 Jan 20; 11(1):52-60. PubMed ID: 14681697
    [Abstract] [Full Text] [Related]

  • 7. Improved neuronal transgene expression from an AAV-2 vector with a hybrid CMV enhancer/PDGF-beta promoter.
    Wang CY, Guo HY, Lim TM, Ng YK, Neo HP, Hwang PY, Yee WC, Wang S.
    J Gene Med; 2005 Jul 20; 7(7):945-55. PubMed ID: 15756650
    [Abstract] [Full Text] [Related]

  • 8. Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs.
    Yew NS, Zhao H, Wu IH, Song A, Tousignant JD, Przybylska M, Cheng SH.
    Mol Ther; 2000 Mar 20; 1(3):255-62. PubMed ID: 10933941
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Partial correction of the alpha-galactosidase A deficiency and reduction of glycolipid storage in Fabry mice using synthetic vectors.
    Przybylska M, Wu IH, Zhao H, Ziegler RJ, Tousignant JD, Desnick RJ, Scheule RK, Cheng SH, Yew NS.
    J Gene Med; 2004 Jan 20; 6(1):85-92. PubMed ID: 14716680
    [Abstract] [Full Text] [Related]

  • 11. Promoters influence the kinetics of transgene expression following adenovector gene delivery.
    Chen P, Tian J, Kovesdi I, Bruder JT.
    J Gene Med; 2008 Feb 20; 10(2):123-31. PubMed ID: 18064718
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS.
    Johansen J, Rosenblad C, Andsberg K, Møller A, Lundberg C, Björlund A, Johansen TE.
    Gene Ther; 2002 Oct 20; 9(19):1291-301. PubMed ID: 12224012
    [Abstract] [Full Text] [Related]

  • 15. Time course of gene expression after plasmid DNA gene transfer to the liver.
    Herweijer H, Zhang G, Subbotin VM, Budker V, Williams P, Wolff JA.
    J Gene Med; 2001 Oct 20; 3(3):280-91. PubMed ID: 11437333
    [Abstract] [Full Text] [Related]

  • 16. Hepatocyte-specific gene expression from integrated lentiviral vectors.
    Nash KL, Jamil B, Maguire AJ, Alexander GJ, Lever AM.
    J Gene Med; 2004 Sep 20; 6(9):974-83. PubMed ID: 15352070
    [Abstract] [Full Text] [Related]

  • 17. Activator protein 1-mediated transcriptional regulation strategy sustains long-term expression of a xenogeneic gene product in vivo: an implication for gene therapy targeting congenital protein deficiencies.
    Sasaki S, Smith JM, Takase K, Okuda K, Ishii N, Takeshita F.
    Int J Mol Med; 2006 Aug 20; 18(2):289-97. PubMed ID: 16820937
    [Abstract] [Full Text] [Related]

  • 18. Optimization of plasmid vectors for high-level expression in lung epithelial cells.
    Yew NS, Wysokenski DM, Wang KX, Ziegler RJ, Marshall J, McNeilly D, Cherry M, Osburn W, Cheng SH.
    Hum Gene Ther; 1997 Mar 20; 8(5):575-84. PubMed ID: 9095409
    [Abstract] [Full Text] [Related]

  • 19. Transient siRNA-mediated attenuation of liver expression from an alpha-galactosidase A plasmid reduces subsequent humoral immune responses to the transgene product in mice.
    Chu Q, Joseph M, Przybylska M, Yew NS, Scheule RK.
    Mol Ther; 2005 Aug 20; 12(2):264-73. PubMed ID: 15946902
    [Abstract] [Full Text] [Related]

  • 20. Muscle creatine kinase/SV40 hybrid promoter for muscle-targeted long-term transgene expression.
    Takeshita F, Takase K, Tozuka M, Saha S, Okuda K, Ishii N, Sasaki S.
    Int J Mol Med; 2007 Feb 20; 19(2):309-15. PubMed ID: 17203206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.